Astrazeneca Pharma India Balance Sheet Annual

Trade

BSE: 506820 | NSE: ASTRAZEN | ISIN: INE203A01020 | Sector: Major Drugs

6,455.40 +118.50 (1.87%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	505.84	497.84	439.60	349.33
Short Term Investments	17.88	0.06	0.09	0.00
Cashand Short Term Investments	523.72	500.40	448.51	352.34
Accounts Receivable- Trade Net	153.13	109.31	87.71	86.64
Total Receivables Net	153.25	132.50	104.98	97.84
Total Inventory	227.88	190.66	141.32	160.18
Other Current Assets Total	27.85	0.14	0.04	0.01
Total Current Assets	932.71	835.47	705.67	618.76
Property/ Plant/ Equipment Total- Net	64.84	70.19	76.69	84.98
Intangibles Net	2.11	-	-	-
Long Term Investments	2.47	3.10	2.93	-
Note Receivable- Long Term	52.90	55.44	54.97	56.43
Other Long Term Assets Total	23.00	20.67	16.30	14.54
Total Assets	1,078.03	984.87	856.56	774.71
Accounts Payable	196.51	227.88	188.06	178.37
Current Portof LT Debt/ Capital Leases	1.81	3.52	3.61	3.51
Other Currentliabilities Total	158.80	100.55	74.16	57.97
Total Current Liabilities	357.12	383.93	332.65	303.50
Capital Lease Obligations	2.78	3.69	5.02	8.63
Total Long Term Debt	2.78	3.69	5.02	8.63
Total Debt	4.60	7.21	8.63	12.14
Other Liabilities Total	6.21	8.56	7.50	6.41
Total Liabilities	366.11	396.18	345.17	318.54
Common Stock Total	5.00	5.00	5.00	5.00
Retained Earnings( Accumulated Deficit)	706.92	581.12	504.44	449.58
Total Equity	711.92	588.69	511.39	456.17
Total Liabilities Shareholders' Equity	1,078.03	984.87	856.56	774.71
Total Common Shares Outstanding	2.50	2.50	2.50	2.50
Tangible Book Valueper Share Common Eq	283.92	235.48	204.56	182.47
Cash	-	2.50	8.82	3.01
Prepaid Expenses	-	11.77	10.82	8.39
Property/ Plant/ Equipment Total- Gross	-	180.45	171.03	163.80
Accumulated Depreciation Total	-	-110.26	-94.34	-78.82
Accrued Expenses	-	51.98	66.82	63.65
Notes Payable/ Short Term Debt	-	0.00	0.00	0.00
ESOP Debt Guarantee	-	2.57	1.95	1.59